Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial by Keerati Chareancholvanich et al.
Chareancholvanich et al. BMC Musculoskeletal Disorders 2012, 13:124
http://www.biomedcentral.com/1471-2474/13/124RESEARCH ARTICLE Open AccessTemporary clamping of drain combined with
tranexamic acid reduce blood loss after total
knee arthroplasty: a prospective randomized
controlled trial
Keerati Chareancholvanich*, Pichet Siriwattanasakul, Rapeepat Narkbunnam and
Chaturong PornrattanamaneewongAbstract
Background: Total knee arthroplasty (TKA) is associated with a significant blood loss. Several methods have been
reported to reduce postoperative blood loss and avoid homologous blood transfusions. In this study, we
investigated the efficacy of temporary clamping of the drain either or not in combination with tranexamic acid
administration for controlling blood loss after TKA.
Methods: The prospective, randomized, and double-blinded study was conducted in our institute. Total of 240
patients, who diagnosed primary osteoarthritis and scheduled to undergo a primary TKA,,were randomized into one
of the four groups: Group A or control group, the drain was not clamped and the patient received a placebo;
Group B, the drain was not clamped and the patient received tranexamic acid; Group C, the drain was clamped and
the patient received a placebo; and Group D, the drain was clamped and the patient received tranexamic acid. The
volume of drained blood at 48 hours postoperatively, the decreasing of hemoglobin (Hb) level at 12 hours
postoperatively and the number of patients requiring blood transfusion were recorded and compared.
Results: The mean postoperative volumes of drained blood and the amount of blood transfusion in the three
study groups (group B, C and D) were significantly lower than those in the control group (p< 0.05), which group D
had the lowest values. Furthermore, group B and D could maintain the Hb level better than group A and C
(p< 0.001). In terms of blood transfusions rate, although the patients in group D required transfusion less than
group A and C (p< 0.05), there was no significant difference between group D and B. The relative risks for
transfusion requirement were 4.4 for group A, 1.4 for group B and 3.0 for group C when compared to group D.
Conclusions: The clamping of drain combined with tranexamic acid administration could reduce postoperative
blood loss and blood transfusion after TKA, significantly greater than using tranexamic acid or drain clamping alone.
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Total knee arthroplasty (TKA) is one of the effective
treatments for severe osteoarthritic knee. The goals of
this procedure include correcting deformity, restoring
pain-free motion and maintaining stability of the knee.
Currently, TKA is widely acknowledged to be one of the
most successful and cost-effective procedures in ortho-
pedic practice. However, considerable blood loss after
TKA is still problematic and postoperative blood transfu-
sion carries a substantial risk of both immunologic reac-
tion and transmission of diseases [1]. Blood transfusion
also involves an additional cost, so a reduction in its use
is very important.
Several methods have been reported to reduce post-
operative blood loss and avoid homologous blood
transfusion. The methods shown to be effective in-
clude autologous blood transfusion [2], postoperative
blood salvage [3-5], intramedullary femoral plug [6],
hypotensive anesthesia [7], cryotherapy with Robert
Jones bandage [8], fibrin tissue adhesive [9,10], drain
clamping [11-18], and tranexamic acid administration
[19-29].
Although most of the surgeons performed TKAs with
the use of tourniquet, postoperative blood loss still oc-
curred. Most of the blood loss in TKA occurs during the
first few postoperative hours [30]. The drain clamping is
one of the methods proposed to reduce blood loss in
early postoperative period of TKA. Various protocols of
this method have been reported [11-18]. For examples,
Sakihara et al. [11] infused 50 ml of saline containing
antibiotic into the knee joint through the drain tube and
clamped the drain for 1 hour. Shen et al. [15] clamped
the drain for 4 hours. Tsumara et al. [16] clamped the
drain for 30 minutes with intra-articular injection of sa-
line with adrenaline. Prasad et al. [17] recommended
using 2-hour clamping of the drain and release for 10
minutes. All of these previous studies proved that the
uses of their methods could reduce blood loss and trans-
fusion requirement following TKA. Nevertheless, some
studies reported that drain clamping had no benefit in
routine TKA [31].
Tranexamic acid is a synthetic anti-fibrinolytic drug
used to prevent bleeding. Initially, fibrinolysis is stimu-
lated by surgical trauma [32,33] and further augmented
by the use of a tourniquet [34,35]. This phenomenon
may lead to increase blood loss after TKA, especially
during the first few postoperative hours. Administration
of tranexamic acid can inhibit the activation of plas-
minogen to plasmin [36,37] by blocking the lysine bind-
ing sites of plasminogen to fibrin, which results in
inhibition of fibrinolysis [38,39].
Several studies reported that tranexamic acid could re-
duce either blood loss or blood transfusions [19-23].
While some studies demonstrated its efficacy in reducingblood loss but not reducing blood transfusion [24,25].
Hynes et al. [26] found that tranexamic acid also could
reduce the decreasing of hemoglobin (Hb) level following
TKA. Nevertheless, Engel et al. [40] revealed that tranex-
amic acid did not cause a significant modulation of fibrin-
olysis variables or a significant reduction of postoperative
bleeding and transfusion requirements.
Based on the level I evidences, meta-analyses showed
that intravenous tranexamic acid appears effective and
safe in reducing allogeneic blood transfusion and blood
loss in TKA without increasing the risk of thrombo-
embolic complications [28,29]. To our knowledge, no
study has compared the efficacy of drain clamping com-
bined with tranexamic acid administration in the control
of bleeding following TKA. Thus, the purpose of this
study was to evaluate the efficacy of drain clamping
alone, tranexamic acid alone and the combination of
these two modalities in the control of bleeding following
TKA.
Methods
This study was designed as a prospective, randomized,
double-blinded, controlled trial and approved by the
Ethics committee of Siriraj Hospital. All patients gave
their written informed consent for participation in the
study. Between June and November 2008, 240 patients
who scheduled to undergo a unilateral primary TKA
were enrolled in the study. The patients aged less than
85 years and diagnosed primary osteoarthritic knees
were included. The exclusion criteria were the patients
who had secondary osteoarthritis (such as rheumatoid
arthritis, post-traumatic arthritis, gouty arthritis, post-
septic arthritis), high risk medical co-morbidity, history
of thromboembolic disease, bleeding disorder, known al-
lergy to tranexamic acid, and receiving the anti-coagulant
drugs.
A computer-generated list was created by the blocks-
of-12 randomization method. The patients were ran-
domly assigned to one of the four groups: group A was
non-clamping of drain and placebo administration,
group B was non-clamping of drain and tranexamic acid
administration, group C was clamping of drain and pla-
cebo administration and group D was clamping of drain
and tranexamic acid administration. The concealed
envelopes were used to blind the surgeon and partici-
pants for the randomization sequences and opened by
a second year resident, who was not involved in the
study.
Our senior author (KC), who is experienced in TKA,
performed all of the operations on patients who were
under spinal anesthesia. A pneumatic tourniquet with a
pressure of 350 mmHg was inflated after limb exsangui-
nations. A straight skin incision and a mini-medial para-
patellar capsular incision were used in all knees. The
Table 1 Pre-operative data
Characteristics Group A Group B Group C Group D p-value
(n = 60) (n = 60) (n = 60) (n = 60)
Male : Female 8 : 52 9 : 51 10 : 50 8 : 52 0.946
Age (yr)* 69.8 ± 6.3 69.4 ± 6.3 68.9 ± 7.5 70.1 ± 7.2 0.418
Pre-op Hb (g/dl)* 12.5 ± 1.1 12.4 ± 1.1 12.4 ± 1.1 12.6 ± 1.0 0.515
* Data was presented as mean ± standard deviation.
Pre-op Hb = Preoperative hemoglobin.
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bearing design (Zimmer, Warsaw, Indiana), inserted
with cement, was used. An intramedullary femoral
alignment rod was used in all cases, and the femoral
canal was filled with a bone plug before the prosthetic
implantation.
In group B and D that received tranexamic acid proto-
col, 10 mg/kg of intravenous tranexamic acid (Transa-
min; 250 mg/5 ml, OLIC, Thailand) was administrated at
10 minutes before inflating the tourniquet and 10 mg/kg
at 3 hours postoperatively. Then, 1500 mg per day of
oral-formed tranexamic acid (Transamin; 250 mg/capsule,
OLIC, Thailand) was given for 5 days after operation.
While in group A and C, the placebo (equivalent volume
of physiologic saline combined with a starch capsule) was
administrated instead.
At the end of the operation, a number-10-gauge drain
was placed intra-articularly and was connected to the
Ultravak pressure drainage bottle (Poly Medicure Limited,
India). After wound closure, a compressive Robert Jones
bandage and a posterior splint were applied. Following the
release of tourniquet pressure, the drain in group A and B
was immediately released and the drain in group C and D
was clamped following our protocol, so called 3-hour-
interval clamping technique (clamped for 3 hours,
released for 3 hours, reclamped for 3 hours and then the
clamp was run continuously).
The patient was encouraged to perform a mechanical
ankle pumping exercise to prevent deep vein thrombosis
as soon as possible after surgery. The bandage, splint
and Foley catheter were removed on the first post- op-
erative day. On the same day, the range-of-motion exer-
cise, an isometric/isotonic quadriceps exercise, a straight
leg rising exercise and a walking exercise were initiated
under the control of a physiotherapist.
The amount of drained blood was recorded at 48 hrs.
All suction drains were removed 48 hours postopera-
tively. The Hb levels were determined preoperatively and
12 hours postoperatively. The patients received a transfu-
sion of one unit of packed red cells (PRC), if their Hb
levels decreased to <10 g/dL or if the compromised clin-
ical criteria (e.g., tachycardia, hypotension, or symptoms
of anemia that were relative to the preoperative medical
condition of the patient) necessitated transfusion. If Hb
levels decreased to <8 g/dL, the patient received two
units of PRC. Following the blood transfusions, we ree-
valuated Hb levels at 6 hours after the end of the transfu-
sion period, and blood replacement was considered again
using the same criteria as outlined above. At 48 hours
after the operation, the Hb levels of all patients were
recorded. Clinical thromboembolic events and wound
complications were also examined. All of the patients
were discharged from the hospital on the fifth day after
the operation.Statistical analysis
The data were analyzed using the commercially available
SPSS statistics software, version 13.0. Quantitative data
were presented as the mean± standard deviation and dif-
ferences in the means among the four groups were ana-
lyzed using an analysis of variance (ANOVA). We
determined differences in sex and the number of
patients requiring blood transfusions using the Chi-
square test. The risks of blood transfusion compared
between groups were analyzed using logistic regression.
P values< 0.05 were regarded as statistically significant.
Results
Over a six-month period, 240 patients (60 patients per
group) were available for analysis. The mean age of the
patients was 69.8 ± 6.8 (range from 53–84) years. The
preoperative data included age, gender and preoperative
Hb were comparable among the four groups (Table 1).
The mean postoperative volumes of drained blood were
1182 ± 411 ml in group A, 724 ± 246 ml in group B,
821 ± 337 ml in group C, and 526 ± 222 ml in group D.
Group A had significantly higher volume of drained
blood than the others (p< 0.001) but there were no sig-
nificant differences in those between group B and C
(p = 0.37). The lowest drained-blood volume was found
in group D (p< 0.001) (Table 2).
The mean levels of decreasing Hb at postoperative 12
hours were 3.3 ± 0.9, 2.1 ± 0.6, 2.8 ± 0.8 and 1.8 ± 0.7 g/dl
in group A, B, C and D, respectively. Group B, C and D
had significantly lower levels of decreasing Hb than
those in group A (p< 0.05). Group B and D could main-
tain the Hb level better than group C (p< 0.001), how-
ever; there was no significant difference between group
D and B (p = 0.07) (Table 2).
The amount of PRC transfusion units required in
group B and D were significantly lower than group A
and C (p< 0.001). There was no significant difference
between group A and C (p = 0.05). The patients who
received the least blood transfusion (0.4 ± 0.5 unit) were
in group D (significantly lower than group B, p< 0.04)
(Table 2). In the number of patients requiring blood
transfusion, group D had significantly lower number
than group A and C (p< 0.05). However there were no
significant difference between group D and B (Table 2).
Table 2 Blood loss and transfusion requirement
Values Group A Group B Group C Group D p-value
(n = 60) (n = 60) (n = 60) (n = 60)
Volume of drained blood 1182± 411 724 ± 246 821± 337 526 ± 222 < 0.001a
(ml)* (420–2260) (230–1330) (230–2020) (180–960)
Decreasing Hb at 12 hours 3.3 ± 0.9 2.1 ± 0.6 2.8 ± 0.8 1.8 ± 0.7 < 0.05b
(g/dl)* (1.3-5.3) (0.9-3.8) (0.9-4.4) (0.4-3.6)
Number of patients requiring blood transfusion 53 (88.3%) 34 (56.7%) 49 (81.7%) 23 (38.3%) < 0.05c
PRC transfusion (unit)* 1.8 ± 1.0 0.7 ± 0.7 1.3 ± 0.9 0.4 ± 0.5 < 0.05d
(0–4) (0–2) (0–3) (0–2)
* Data was presented as mean ± standard deviation and range.
a Statistical difference among all groups (except between group B and C, p = 0.37).
b Statistical difference among all groups (except between group B and D, p = 0.07).
c Statistical difference among all groups (except between group A and C, B and D).
d Statistical difference among all groups (except between group A and C, p = 0.05).
Hb = hemoglobin, PRC = packed red cell.
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for group A, 1.4 for group B and 3.0 for group C when
compared to group D.
In terms of complications, no wound infections or
clinical venous thromboembolisms were detected in all
groups. Although three patients (each one from group
A, B and D) developed postoperative ecchymosis around
the knees, this resolved spontaneously.
Discussion
The significant blood loss and risk for blood transfusion
are important features that must be considered in TKA.
Complications after allogeneic blood transfusions have
been well reported in the previous literature [1]. Several
methods have been reported to reduce blood loss and
blood transfusion after TKA [2-29]. However, the best
method remains unknown. Either drain clamping [11-18]
or tranexamic acid administration [19-29] is the simple
method that we interested. The combined effect of these
two methods was still unknown. We therefore aimed to
study the efficacy of drain clamping alone, tranexamic
acid alone and the combination of these two modalities
in the control of bleeding following TKA.
Because most of the blood loss in TKA occurs during
the first postoperative day (71.1 and 84% in the first 6
and 12 hour after operation, respectively) [41,42], it
seems reasonable to clamp the drain in the early post-
operative period to create a tamponade effect and to
control blood loss. Although various protocols for drain
clamping have been reported in the literature [11-18],
we have established a new interval clamping protocol for
reducing blood loss in TKA. Kiely et al. [31] concluded
that 2 hours of drain clamping has no benefit in routine
TKA. Thus, a longer period of drain clamping may be
required. However, hematoma and wound complications
must be taken into consideration for long-period clamp-
ing protocols. To balance between creating a tamponadeeffect and reducing wound complications, an interval
clamping protocol using a 3-hour interval pattern that
routinely used in our institute was selected for this
study. From the results of this study, our drain clamping
technique alone could reduce more blood loss and keep
higher 12-hour Hb level than the non-clamping group.
Nevertheless, the use of this protocol did not affect the
reduction of transfusion requirement, either amount or
rate.
Fron non-pharmacological to pharmacological method,
there are four routes for administrating tranexamic acid
in order to reduce blood loss in TKA: oral, intramuscu-
lar, intravenous, and intra-articular [27]. The time taken
for maximum plasma levels of tranexamic acid to be
reached has been reported to be 2 hours for oral, 30 min-
utes for intramuscular and 5–15 minutes for intravenous
administration [43,44]. Many clinical studies reported
tranexamic acid reduced blood loss or transfusion
requirements when given on deflation of the tourniquet
with a repeated dose postoperatively [19,20,22-29,45].
Tanaka et al. [27] concluded that the hemostatic effect
was best when tranexamic acid was given once 10 min-
utes before surgery and once upon deflation of the tour-
niquet. The administration before the operation gave
more hemostatic effect than administration upon deflation
of the tourniquet. Pharmacokinetic studies [43,44,46,47]
indicated that a dose of 20 mg/kg of tranexamic acid is
suitable for TKA since therapeutic levels could be
maintained for approximately 8 hours after the oper-
ation, which covered the period of hyperfibrinolysis in
cases of increased blood loss. Thus, we also used a dose
of 20 mg/kg of intravenous tranexamic acid that divided
into two parts: 10 mg/kg at 10 minutes before tourni-
quet inflation and another 10 mg/kg at 3 hours post-
operatively. Then, an oral form of tranexamic acid was
given for 5 days in order to control bleeding during re-
habilitative training.
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that it significantly reduced about 40% of blood loss,
compared to those in control group. This result was in
the same way of previous studies that reported on 30-50%
of blood loss reduction [19-24,27]. Furthermore, our
protocol also showed the superior efficacy in reducing
amount and rate of blood transfusion, and maintaining
the Hb level, over the control group.
The hemostatic effects of the tranexamic acid alone
were significantly better than the drain clamping alone
with regards to the level of decreasing Hb, amount of
blood transfusion and number of patients requiring
blood transfusion, despite the volume of drained blood
between these two methods was not significantly differ-
ent. These findings confirmed that some blood might re-
main around the knee joint, leak through the wound, or
diffuse into the soft tissue, especially when the drain was
clamped [13,48].
Importantly, this study also verified the efficacy of the
administration of tranexamic acid combined with the
drain clamping, which had never been studied before.
Compared to the control group, the use of this combin-
ation could reduce the volume of drained blood up to
55% that significantly more than using the tranexamic
acid alone (40% of reducing blood loss) or the drain
clamping alone (30% of reducing blood loss). Further-
more, this combined method provided the lowest
amount of transfusion unit. For the efficacy in maintain-
ing the Hb level and reducing the rate of transfusion re-
quirement, the use of our tranxenamic acid protocol
combined with the 3-hour interval drain clamping was
proved to give more benefit than using drain clamping
alone. Nevertheless, it was not significantly different
from using tranexamic acid alone. The superior effect of
tranexamic acid over clamping of the drain might ex-
plain this phenomenon. After calculating the relative
risks, the number of patients required blood transfusion
in control group was 4.4-fold, in drain clamping alone
was 3.0-fold and in tranexamic acid alone was 1.4-fold
when compared to the combined method.
There are some limitations in this study. First, the fe-
male to male ratio was high because most patients
undergoing TKA in our country are females. Female
patients may have less preoperative hemoglobin than
male, which may affect the rate of blood transfusion.
Nevertheless, after randomization, the female-to-male
ratios and preoperative hemoglobin levels were not dif-
ferent among the four groups. Second, we used only
clinical evaluations to evaluate the thromboembolic
complications that could not detect asymptomatic deep
vein thrombosis and pulmonary embolism. The correl-
ation of using tranexamic acid and venous thrombo-
embolism remains unknown. Third, although we
proposed a 5-day regimen of oral formed tranexamicacid might assist to control blood loss during rehabilita-
tion, there were no measurement tools to assess this hy-
pothesis. Finally, we focused only on the efficacy in
controlling blood loss. This report did not include func-
tional scoring systems or patient satisfaction.
Conclusion
This study proved that 3-hour-interval drain clamping
technique significantly reduced postoperative blood loss
and our tranexamic acid administration protocol signifi-
cantly reduced blood loss and blood transfusion after
TKA. The use of these two combined methods demon-
strated the better hemostatic effect than using tranex-
amic acid alone or drain clamping alone.
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